This 2021 edition of Reported Tuberculosis in the United States reflects ongoing challenges facing the public health and tuberculosis (TB) communities. The report describes information on cases of TB disease reported to CDC since 1993. This year’s report emphasizes cases counted by the reporting areas in 2021 and the ongoing effects of the COVID-19 pandemic on TB surveillance.
WHO has published a global TB report every year since 1997. The main aim of the report is to provide a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease at global, regional and country levels. This report is updated annually.
WHO has published a global TB report every year since 1997. The main aim of the report is to provide a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease at global, regional and country levels. This report is updated annually.
This report presents summary data for U.S. TB cases reported to the Division of TB Elimination, CDC, during 2019.
The information included in this report provide preliminary data on HIV diagnoses and linkage to HIV medical care reported to CDC as of June 2020 for the years 2019 and 2020.
This slide set analyzes trends in rates and distributions of deaths in the United States.
The surveillance survey provides information on health behaviors that contribute markedly to the leading causes of death, disability, and social problems among youth and adults in the United States.
This report provides diagnoses of HIV infection among adolescents and young adults in the United States and 6 Dependent areas.
This annual surveillance report, summarizes information about reported cases of hepatitis A, hepatitis B, and hepatitis C and deaths with either of these hepatitis listed as a cause of death in CDC’s National Vital Statistics System (NVSS).
DASH’s Strategic Plan articulates the vision, framework, and overarching goals and strategies that guide the division’s programmatic, research and surveillance efforts through 2025.
